REBEKA LEWIS: Open Payments
NPI 1356104913 · SAINT GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,144 in 118 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $2,144
Food & beverage: $2,144
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 41 | $486 |
| Otsuka America Pharmaceutical, Inc. | 16 | $420 |
| ABBVIE INC. | 16 | $240 |
| Janssen Pharmaceuticals, Inc | 9 | $220 |
| E.R. Squibb & Sons, L.L.C. | 11 | $192 |
| Vanda Pharmaceuticals Inc. | 3 | $101 |
| Lundbeck LLC | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Alkermes, Inc. | 2 | $52 |
Products named: AUSTEDO XR, REXULTI, VRAYLAR, SPRAVATO, COBENFY, ABILIFY MAINTENA, FANAPT, TRINTELLIX.
Industry payments across UT — which companies pay providers there.
